Conference Agenda (Subject to Change Without Notice) Click here for a PDF version of the agenda
November 3rd
5:00 - 9:00 PM	CEO Evening Gala Reception & Dinner (To sign up for the pre-conference CEO Dinner, please go to: https://www.123signup.com/register?id=jyrdn) Featuring Entertainment by Physician-Turned-Stand-Up-Comedian Matt Iseman Matt Iseman is a licensed physician and a professional comedian. Building on his improvisational background with the Groundling's in Los Angeles, Iseman was a regular on E! Entertainment's former hit "Talk Soup." He hosts E!'s newest reality show, "Scream Play." Other television appearances include co-hosting "The Glutton Bowl," a primetime FOX special, "The Drew Carey Show" and "Mad Men" ... Click here for more info
November 4
7:00 AM	Registration Open
7:45 AM	Breakfast & Opening Remarks
8:00 AM	Morning Keynote Presentation Featuring Internationally-Renowned Author and Futurist  Joel Kotkin Mr. Kotkin will talk about strategies to maintain and increase California's economic and technological competitiveness in a rapidly changing world economy.  Described by the New York Times as America’s “uber-geographer,” for over three decades Mr. Kotkin has been one of the nation's most prolific and widely-published journalists. He is a highly respected speaker and futurist, he consults for many leading economic development organizations, private companies, regions and cities.  Most recently, he wrote "THE NEXT HUNDRED MILLION: America in 2050," a book published in February 2010 by The Penguin Press. The book explores how the nation will evolve in the next four decades. It has received rave reviews from The New York Times, Wall Street Journal, the Globe and Mail, and National Public Radio... Click here to read more about Mr. Kotkin
9:00 AM	Break
9:15 AM	Company Presentations (Group A)
	Track I:  Biochips & Biomemtic Systems (Platinum Salon A) o       Librede (Cell-free disposable biochip for ion channel measurement) o       Matrix Sensors (Disposable microchips to detect biological and chemical molecules) o       ChromoLogic (Biomemtic systems) Track II: Therapeutic and Monitoring Devices (Platinum Salon B) ·        Replenish (Implantable drug delivery device to treat ophthalmic diseases) ·        Lerner Medical Devices (Use of light to treat skin disease) ·        SonarMed (Airway Monitoring System) o       NeuroSystec (Fully implantable drug delivery devices for treating hearing disorders) Track III: Molecular Diagnostics (Platinum Salon C) o       DxTerity Diagnostics (A medical device for rapid genomic tests) o       MEDomics (DNA diagnostic testing for mitochondrial diseases) o       Oracle Biosciences (Theranostic breast cancer biomarkers) o       NanoVega (Biotags for detecting cancer) Track IV: Protein Therapeutics (Platinum Salon D) o       Xencor Corporation (Protein engineering to treat autoimmune disease and cancer) o       Paganini Lifesciences (Antibodies for treating retinal disease) o       Neumedicines (Protein therapeutics for hematopoietic disorders) ·        Applied Integrin Sciences (Recombinant peptides that modulate human integrin receptors for cancer therapeutics
10:30 AM	Coffee Break
10:45 AM	Company Presentations (Group B)
	Track I: Regenerative Medicine (Platinum Salon A) o       ProteinLinks (Induced pluripotent stem cells) o       California Stem Cells Inc. (High-purity human cells for drug development and therapeutic application) o       Q Therapeutics (Stem cell platform to treat CNS disorders) o       EOS Neurosciences (Treatments for blindness and other serious neurological conditions using optogenetic and gene therapy approaches) Track II: Therapeutic and Diagnostic Devices (Platinum Salon B) o       CryoCare: Cryoablation therapy for women healthcare o       C-Tech: Dialysis device o       Ocutronics: Retinal photography for early detection of diabetic retinopathy o       MiniPumps, Inc.: miniaturized implantable pumps for drug delivery Track III: Imaging, Informatics & Botanicals (Platinum Salon C) ·        Imaging: o       Radius Health (Light and portable radiology tools) o       Sofie Biosciences (Molecular imaging) ·        Nutriceuticals: o       Plantiva (Manufactures and sells proprietary botanical health products) ·        Health Informatics: o       DPS Health (health informatics tools for diabetes and weight management)
	Track IV: Vaccines (Platinum Salon D) o       ImmunoCellular Therapeutics (Immunotherapeutics for brain cancer) o       Espis Vaccines (Immunotherapies to treat drug-resistant infectious disease) o       NovaDigm (Vaccines to protect patients from hard to treat fungal and bacterial infections)
12:30 PM	Networking Luncheon
1:00 PM	Luncheon Keynote Presentation by COO of Celgene  Perry Karsen Mr. Karsen's keynote will focus on collaboration trends during and following the current economic downturn. It will target executives at emerging medical device, biotech and healthcare informatics firms by building on this year's conference theme: "Sustaining Innovation in a Challenging Economy." Most recently, Mr. Karsen served as president and CEO of Pearl Therapeutics, which develops double and triple combination therapies for highly prevalent respiratory diseases. From 2004-2009, he served as senior vice president and head of worldwide business development for Celgene Corporation (his current employer), where he was also president of the Asia/Pacific Region. Prior to joining Celgene, he was senior vice president of business development at Human Genome Sciences (NASDAQ: HGSI - News). ... Click here to read press release
2:00 PM	Break
2:15 PM	Concurrent Breakout Sessions (Group A)
	Session A- I Funding Through Corporate Partnerships Get the inside track on negotiating and maintaining strategic partnerships with established biopharma, IVD and device companies. Speakers:  Rajendra V. Deshpande, Ph.D., Senior Director, Emerging Technologies, Corporate Office of Science and Technology, Johnson & Johnson, Inc. Edger "Ed" Ellsworth, Director Corporate Alliances, Primary Care Diagnostics, Beckman Coulter, Inc. Traci Libby, CLP, Director, Corporate Development, Life Technologies Corporation Monty Mars, Sr. Director Corporate Development, Edwards LifesSciences, Inc. Bob Raynor, Director, Corporate Business Development, Beckman Coulter, Inc.
	Session A-II Preparing for Financing Transactions - VC/PE, Partnerships and/or IPOs Mike Bryant, Partner, Ernst & Young Bill Lewis, Bolton & Company Jack Garza, Silicon Valley Bank John Smither, CFO Kythera Biopharmaceuticals
	Session A-III Life-Science VC Investing Trends What is hot and what is not Paul Grand, Research Corporation Technology Joe Boystak,  Brightwaters Capital Alex Suh, California Technology Ventures Others TBA
	Session A-IV Government Funding Opportunities (What Is New at the National Institutes of Health) All you need to know about grant funding from NIAID, NCI, DARPA and the Army Ali Andalibi, National Cancer Institute Greg Milman, National Institute of Allergy and Infectious Diseases
3:30 PM	Coffee and Snack Break
3:45 PM	Concurrent Breakout Sessions (Group B)
	Session B-I IP Strategies for Managing the Dynamics of Risk, Innovation, and Globalization Risk, including the risk of infringing third party IP, is inherent in innovation of new products and their commercialization in a global marketplace.  However, there are steps companies can take to manage and mitigate the risk.  We will discuss strategies for assessing and managing risk via patent landscape analyses and strategies for developing exclusivity in the marketplace thereby minimizing competition, so as to enhance revenue potential and opportunities for investment. Speakers: Mark Benedict, Partner, Knobbe Martens Josue Villalta, Partner, Knobbe Martens Company Rep (TBD)
	Session B-II What Do Angels Look for These Days Meet and interact with local angel investors with interest in biotech and device technologies. get to know what it takes and how to raise angel money Speakers: Bill Barber, President, Maverick Angels Connie Koch, Keiretsu Forum Frank Singer, Founder, Tech Coast Angels
	Session B-III Funding Prospects in a Changing Regulatory Environment Learn about the changing culture of the new FDA and how to adjust to new regulatory requirements such as the new 510(k) guidance Speakers: Russ Olson, RCRI, Inc. Michael A. Swit, The Weinberg Group Inc. Anne Tomalin, CanReg, Inc.
	Session B-IV Government Funding Opportunities (How to Access DoD Grants and Contracts) David Hood, DH3 & Associates, Former Senior Advisor for the Principal Assistant for Acquisitions, US Army MRMC Jack Judy, DARPA
5:30 PM	Cocktail Reception & Innovation Alley
7:00 PM	Conference Adjourns

Thanks to Leading Sponsors

Media Supporters

ExcelPR Group

PRVIDEO.TV